142 related articles for article (PubMed ID: 23246297)
1. CD4 lymphopenia to identify end-of-life metastatic cancer patients.
Péron J; Cropet C; Tredan O; Bachelot T; Ray-Coquard I; Clapisson G; Chabaud S; Philip I; Borg C; Cassier P; Labidi Galy I; Sebban C; Perol D; Biron P; Caux C; Menetrier-Caux C; Blay JY
Eur J Cancer; 2013 Mar; 49(5):1080-9. PubMed ID: 23246297
[TBL] [Abstract][Full Text] [Related]
2. CD4 lymphopenia as a risk factor for febrile neutropenia and early death after cytotoxic chemotherapy in adult patients with cancer.
Borg C; Ray-Coquard I; Philip I; Clapisson G; Bendriss-Vermare N; Menetrier-Caux C; Sebban C; Biron P; Blay JY
Cancer; 2004 Dec; 101(11):2675-80. PubMed ID: 15503313
[TBL] [Abstract][Full Text] [Related]
3. Patients with metastatic breast cancer leading to CD4+ T cell lymphopaenia have poor outcome.
Trédan O; Manuel M; Clapisson G; Bachelot T; Chabaud S; Bardin-dit-Courageot C; Rigal C; Biota C; Bajard A; Pasqual N; Blay JY; Caux C; Ménétrier-Caux C
Eur J Cancer; 2013 May; 49(7):1673-82. PubMed ID: 23265706
[TBL] [Abstract][Full Text] [Related]
4. Identification of patients at risk for early death after conventional chemotherapy in solid tumours and lymphomas.
Ray-Coquard I; Ghesquière H; Bachelot T; Borg C; Biron P; Sebban C; LeCesne A; Chauvin F; Blay JY;
Br J Cancer; 2001 Sep; 85(6):816-22. PubMed ID: 11556830
[TBL] [Abstract][Full Text] [Related]
5. Pre-treatment lymphopenia as a prognostic biomarker in colorectal cancer patients receiving chemotherapy.
Cézé N; Thibault G; Goujon G; Viguier J; Watier H; Dorval E; Lecomte T
Cancer Chemother Pharmacol; 2011 Nov; 68(5):1305-13. PubMed ID: 21448592
[TBL] [Abstract][Full Text] [Related]
6. Lymphopenia: a new independent prognostic factor for survival in patients treated with whole brain radiotherapy for brain metastases from breast carcinoma.
Claude L; Perol D; Ray-Coquard I; Petit T; Blay JY; Carrie C; Bachelot T
Radiother Oncol; 2005 Sep; 76(3):334-9. PubMed ID: 16024123
[TBL] [Abstract][Full Text] [Related]
7. Immune reconstitution after autologous hematopoietic stem cell transplantation in relation to underlying disease, type of high-dose therapy and infectious complications.
Steingrimsdottir H; Gruber A; Björkholm M; Svensson A; Hansson M
Haematologica; 2000 Aug; 85(8):832-8. PubMed ID: 10942930
[TBL] [Abstract][Full Text] [Related]
8. Biological, histological, and clinical impact of preoperative IL-2 administration in radically operable gastric cancer patients.
Romano F; Cesana G; Berselli M; Gaia Piacentini M; Caprotti R; Bovo G; Uggeri F
J Surg Oncol; 2004 Dec; 88(4):240-7. PubMed ID: 15565596
[TBL] [Abstract][Full Text] [Related]
9. Prognostic value of CD4+ T lymphopenia in non-small cell lung Cancer.
Eberst G; Vernerey D; Laheurte C; Meurisse A; Kaulek V; Cuche L; Jacoulet P; Almotlak H; Lahourcade J; Gainet-Brun M; Fabre E; Le Pimpec-Barthes F; Adotevi O; Westeel V
BMC Cancer; 2022 May; 22(1):529. PubMed ID: 35546670
[TBL] [Abstract][Full Text] [Related]
10. Lymphopenia associated with adjuvant anthracycline/ taxane regimens.
Tolaney SM; Najita J; Winer EP; Burstein HJ
Clin Breast Cancer; 2008 Aug; 8(4):352-6. PubMed ID: 18757263
[TBL] [Abstract][Full Text] [Related]
11. Lymphopenia as a prognostic factor for overall survival in advanced carcinomas, sarcomas, and lymphomas.
Ray-Coquard I; Cropet C; Van Glabbeke M; Sebban C; Le Cesne A; Judson I; Tredan O; Verweij J; Biron P; Labidi I; Guastalla JP; Bachelot T; Perol D; Chabaud S; Hogendoorn PC; Cassier P; Dufresne A; Blay JY;
Cancer Res; 2009 Jul; 69(13):5383-91. PubMed ID: 19549917
[TBL] [Abstract][Full Text] [Related]
12. Long-term kinetics of a T-lymphocytes subset in kidney transplant recipients: relationship with posttransplant malignancies.
Glowacki F; Al Morabiti M; Lionet A; Labalette M; Provot F; Noel C; Hazzan M
Transplant Proc; 2009 Oct; 41(8):3323-5. PubMed ID: 19857742
[TBL] [Abstract][Full Text] [Related]
13. Treatment of AIDS-related lymphomas: rituximab is beneficial even in severely immunosuppressed patients.
Wyen C; Jensen B; Hentrich M; Siehl J; Sabranski M; Esser S; Gillor D; Müller M; Van Lunzen J; Wolf T; Bogner JR; Wasmuth JC; Christ H; Fätkenheuer G; Hoffmann C
AIDS; 2012 Feb; 26(4):457-64. PubMed ID: 22112600
[TBL] [Abstract][Full Text] [Related]
14. [Treatment outcomes and clinicopathologic characteristics of advanced triple-negative breast cancer patients].
Zhang P; Xu BH; Ma F; Li Q; Yuan P; Wang JY; Zhang P
Zhonghua Zhong Liu Za Zhi; 2011 May; 33(5):381-4. PubMed ID: 21875471
[TBL] [Abstract][Full Text] [Related]
15. Lymphocyte subsets in renal transplant recipients with de novo genitourinary malignancies.
Guichard G; Rebibou JM; Ducloux D; Simula-Faivre D; Tiberghien P; Chalopin JM; Bittard H; Saas P; Kleinclauss F
Urol Int; 2008; 80(3):257-63. PubMed ID: 18480627
[TBL] [Abstract][Full Text] [Related]
16. The ratio of intra-tumoral regulatory T cells (Foxp3+)/helper T cells (CD4+) is a prognostic factor and associated with recurrence pattern in gastric cardia cancer.
Kim HI; Kim H; Cho HW; Kim SY; Song KJ; Hyung WJ; Park CG; Kim CB
J Surg Oncol; 2011 Dec; 104(7):728-33. PubMed ID: 21792941
[TBL] [Abstract][Full Text] [Related]
17. Kinetics of T-lymphocyte subsets and posttransplant opportunistic infections in heart and kidney transplant recipients.
Calarota SA; Zelini P; De Silvestri A; Chiesa A; Comolli G; Sarchi E; Migotto C; Pellegrini C; Esposito P; Minoli L; Tinelli C; Marone P; Baldanti F
Transplantation; 2012 Jan; 93(1):112-9. PubMed ID: 22134368
[TBL] [Abstract][Full Text] [Related]
18. Early lymphopenia as a risk factor for chemotherapy-induced febrile neutropenia.
Choi CW; Sung HJ; Park KH; Yoon SY; Kim SJ; Oh SC; Seo JH; Kim BS; Shin SW; Kim YH; Kim JS
Am J Hematol; 2003 Aug; 73(4):263-6. PubMed ID: 12879430
[TBL] [Abstract][Full Text] [Related]
19. T lymphocytes and fractalkine contribute to myocardial ischemia/reperfusion injury in patients.
Boag SE; Das R; Shmeleva EV; Bagnall A; Egred M; Howard N; Bennaceur K; Zaman A; Keavney B; Spyridopoulos I
J Clin Invest; 2015 Aug; 125(8):3063-76. PubMed ID: 26168217
[TBL] [Abstract][Full Text] [Related]
20. Lymphocytic subpopulation changes after open and laparoscopic cholecystectomy: a prospective and comparative study on 38 patients.
Cristaldi M; Rovati M; Elli M; Gerlinzani S; Lesma A; Balzarotti L; Taschieri AM
Surg Laparosc Endosc; 1997 Jun; 7(3):255-61. PubMed ID: 9194291
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
